Clinical Trial Details
| Trial ID: | L2433 |
| Source ID: | NCT00694057 |
| Associated Drug: | He3286 |
| Title: | Safety, Tolerance and Activity of HE3286 in Patients With Type 2 Diabetes Mellitus |
| Acronym: | |
| Status: | COMPLETED |
| Study Results: | NO |
| Results: | |
| Conditions: | Type 2 Diabetes Mellitus |
| Interventions: | DRUG: HE3286|DRUG: Placebo |
| Outcome Measures: | Primary: To evaluate the change in HbA1c from baseline to week 12 in the HE3286 treated group when compared to the placebo group., 12-weeks|To evaluate the safety and tolerance of HE3286 10 mg per day (5 mg BID) compared to placebo from baseline to week 12., 12-weeks | Secondary: To evaluate the effect of HE3286 on fasting blood glucose over time., 12-weeks|To evaluate the effect of HE3286 on insulin sensitivity over time., 12-weeks |
| Sponsor/Collaborators: | Sponsor: Harbor Therapeutics |
| Gender: | ALL |
| Age: | ADULT, OLDER_ADULT |
| Phases: | PHASE2 |
| Enrollment: | 164 |
| Study Type: | INTERVENTIONAL |
| Study Designs: | Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT |
| Start Date: | 2008-06 |
| Completion Date: | 2010-01 |
| Results First Posted: | |
| Last Update Posted: | 2011-06-14 |
| Locations: | Anaheim, California, 92801, United States|Anaheim, California, 92805, United States|Beverly Hills, California, 90211, United States|Buena Park, California, 90620, United States|Burbank, California, 91505, United States|Carmichael, California, 95608, United States|Escondido, California, 92025, United States|Fresno, California, 93726, United States|Huntington Park, California, 90255, United States|Long Beach,, California, 90806, United States|Los Angeles, California, 90057, United States|National City, California, 91950, United States|Roseville, California, 95661, United States|Chicago, Illinois, 60616, United States|Baton Rouge, Louisiana, 70808, United States|St. Louis, Missouri, 63141, United States|Las Vegas, Nevada, 89106, United States|Las Vegas, Nevada, 89148, United States|El Paso, Texas, 79905, United States|San Antonio, Texas, 78229, United States|Salt Lake City, Utah, 84107, United States|Kenosha, Wisconsin, 53142, United States |
| URL: | https://clinicaltrials.gov/show/NCT00694057 |
| Drug ID | Drug Name | Type | DrugBank ID | Targets | Category | Latest Progress |
|---|